Structure Therapeutics Falls 52%

Structure Therapeutics Inc. (GPCR) shares are falling more than 51 percent on Monday morning trade, on reports that its weight loss and diabetes drug GSBR-1290's performance was weaker than its rival Eli Lilly's orforglipron at eight weeks.

Related Keywords

Eli Lilly ,Structure Therapeutics Inc ,Structure Therapeutics ,Stock Alert ,